Juan Asenjo

Last updated
Juan A. Asenjo de Leuze de Lancizolle Juan A. Asenjo de Leuze de Lancizolle.jpg
Juan A. Asenjo de Leuze de Lancizolle

Professor Juan A. Asenjo (born October 7, 1949) [1] is a Chilean chemical engineer who specialises in biotechnology. He currently serves as the director of the Centre for Biochemical Engineering and Biotechnology at the University of Chile and is the President of the Chilean Academy of Science. [2]

Contents

Education and career

Asenjo studied for his first degree in chemical engineering at the University of Chile, graduating in 1974. He then moved to the University of Leeds, UK to complete an MSc, followed by a PhD at University College London supervised by Peter Dunnill and M. D. Lilly. He moved back to Chile for one year before being appointed Assistant Professor in biochemical engineering at Columbia University, New York where he remained until 1986. In 1987 he moved to the University of Reading to become a Reader in biochemical engineering and the director of the biochemical engineering laboratory. Then in 1995 he returned to Chile and established the Centre for Biochemical Engineering and Biotechnology at the University of Chile which he continues to direct. [3]

Research

Asenjo has made scientific contributions where the fields of mathematics and computer science merge with biology and biotechnology. This has included developing models of enzyme systems for the lysis of microbial cells [4] and for predicting the behaviour of proteins in aqueous two-phase systems. [5] He has been involved in the purification of several proteins including alpha amylase, [6] tissue plasminogen activator, monoclonal antibodies [7] and virus-like particles. [8] Recently his group have begun working in the fields of protein engineering, metabolic engineering and functional genomics. [2] One specific area of research is an attempt to produce detergents which work at low temperatures based on trypsin enzymes originally isolated from Antarctic krill. [9] [10] The Santiago Times reported in 2013 that Asenjo's group was to begin testing a vaccine for alcoholism on mice and hoped to begin pre-clinical trials in humans later that year. [11] In November 2013 the vaccine was in stage 2 clinical trials. The vaccine acts to inhibit acetaldehyde dehydrogenase causing people to experience a hangover shortly after consuming alcohol. [12]

He has called for Chile to invest more in scientific research and development, which would allow the country to add value to its exports, for example by exporting lithium batteries rather than raw lithium. [13] [14]

Recognition

He was elected as a member of the Chilean Academy of Science in 1999 and was appointed as its Vice President in 2004 and President in 2010. [3] In 2004 he was awarded the Chilean National Prize for Applied Sciences and Technologies, with the jury noting his research was of a high impact and quality, as demonstrated by over 100 publications, several patents and having supervised over 40 doctoral students. [9]

In 2018, Asenjo was elected a member of the National Academy of Engineering for contributions to protein separations for the biotechnology industry and to biotechnology research, development, and entrepreneurship in Chile.

Related Research Articles

Hydrolysis is any chemical reaction in which a molecule of water breaks one or more chemical bonds. The term is used broadly for substitution, elimination, and solvation reactions in which water is the nucleophile.

Lysis is the breaking down of the membrane of a cell, often by viral, enzymic, or osmotic mechanisms that compromise its integrity. A fluid containing the contents of lysed cells is called a lysate. In molecular biology, biochemistry, and cell biology laboratories, cell cultures may be subjected to lysis in the process of purifying their components, as in protein purification, DNA extraction, RNA extraction, or in purifying organelles.

Exoenzyme

An exoenzyme, or extracellular enzyme, is an enzyme that is secreted by a cell and functions outside that cell. Exoenzymes are produced by both prokaryotic and eukaryotic cells and have been shown to be a crucial component of many biological processes. Most often these enzymes are involved in the breakdown of larger macromolecules. The breakdown of these larger macromolecules is critical for allowing their constituents to pass through the cell membrane and enter into the cell. For humans and other complex organisms, this process is best characterized by the digestive system which breaks down solid food via exoenzymes. The small molecules, generated by the exoenzyme activity, enter into cells and are utilized for various cellular functions. Bacteria and fungi also produce exoenzymes to digest nutrients in their environment, and these organisms can be used to conduct laboratory assays to identify the presence and function of such exoenzymes. Some pathogenic species also use exoenzymes as virulence factors to assist in the spread of these disease-causing microorganisms. In addition to the integral roles in biological systems, different classes of microbial exoenzymes have been used by humans since pre-historic times for such diverse purposes as food production, biofuels, textile production and in the paper industry. Another important role that microbial exoenzymes serve is in the natural ecology and bioremediation of terrestrial and marine environments.

Bioreactor

A bioreactor refers to any manufactured device or system that supports a biologically active environment. In one case, a bioreactor is a vessel in which a chemical process is carried out which involves organisms or biochemically active substances derived from such organisms. This process can either be aerobic or anaerobic. These bioreactors are commonly cylindrical, ranging in size from litres to cubic metres, and are often made of stainless steel. It may also refer to a device or system designed to grow cells or tissues in the context of cell culture. These devices are being developed for use in tissue engineering or biochemical/bioprocess engineering.

Recombinant DNA DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

Affinity chromatography is a method of separating a biomolecule from a mixture, based on a highly specific macromolecular binding interaction between the biomolecule and another substance. The specific type of binding interaction depends on the biomolecule of interest; antigen and antibody, enzyme and substrate, receptor and ligand, or protein and nucleic acid binding interactions are frequently exploited for isolation of various biomolecules. Affinity chromatography is useful for its high selectivity and resolution of separation, compared to other chromatographic methods.

Pharming, a portmanteau of "farming" and "pharmaceutical", refers to the use of genetic engineering to insert genes that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a genetically modified organism (GMO). Pharming is also known as molecular farming, molecular pharming or biopharming.

Liquid–liquid extraction (LLE), also known as solvent extraction and partitioning, is a method to separate compounds or metal complexes, based on their relative solubilities in two different immiscible liquids, usually water (polar) and an organic solvent (non-polar). There is a net transfer of one or more species from one liquid into another liquid phase, generally from aqueous to organic. The transfer is driven by chemical potential, i.e. once the transfer is complete, the overall system of chemical components that make up the solutes and the solvents are in a more stable configuration. The solvent that is enriched in solute(s) is called extract. The feed solution that is depleted in solute(s) is called the raffinate. LLE is a basic technique in chemical laboratories, where it is performed using a variety of apparatus, from separatory funnels to countercurrent distribution equipment called as mixer settlers. This type of process is commonly performed after a chemical reaction as part of the work-up, often including an acidic work-up.

Industrial fermentation is the intentional use of fermentation by microorganisms such as bacteria and fungi as well as eukaryotic cells like CHO cells and insect cells, to make products useful to humans. Fermented products have applications as food as well as in general industry. Some commodity chemicals, such as acetic acid, citric acid, and ethanol are made by fermentation. The rate of fermentation depends on the concentration of microorganisms, cells, cellular components, and enzymes as well as temperature, pH and for aerobic fermentation oxygen. Product recovery frequently involves the concentration of the dilute solution. Nearly all commercially produced enzymes, such as lipase, invertase and rennet, are made by fermentation with genetically modified microbes. In some cases, production of biomass itself is the objective, like Single-cell protein and as in the case of baker's yeast and lactic acid bacteria starter cultures for cheesemaking. In general, fermentations can be divided into four types:

Aqueous biphasic systems (ABS) or aqueous two-phase systems (ATPS) are clean alternatives for traditional organic-water solvent extraction systems.

Plasmid preparation

A plasmid preparation is a method of DNA extraction and purification for plasmid DNA. Many methods have been developed to purify plasmid DNA from bacteria. These methods invariably involve three steps:

Immunogenicity is the ability of a foreign substance, such as an antigen, to provoke an immune response in the body of a human or other animal. It may be wanted or unwanted:

This page provides an alphabetical list of articles and other pages about biotechnology.

Fusion protein

Fusion proteins or chimeric (kī-ˈmir-ik) proteins are proteins created through the joining of two or more genes that originally coded for separate proteins. Translation of this fusion gene results in a single or multiple polypeptides with functional properties derived from each of the original proteins. Recombinant fusion proteins are created artificially by recombinant DNA technology for use in biological research or therapeutics. Chimeric or chimera usually designate hybrid proteins made of polypeptides having different functions or physico-chemical patterns. Chimeric mutant proteins occur naturally when a complex mutation, such as a chromosomal translocation, tandem duplication, or retrotransposition creates a novel coding sequence containing parts of the coding sequences from two different genes. Naturally occurring fusion proteins are commonly found in cancer cells, where they may function as oncoproteins. The bcr-abl fusion protein is a well-known example of an oncogenic fusion protein, and is considered to be the primary oncogenic driver of chronic myelogenous leukemia.

In enzymology, nitrile hydratases are mononuclear iron or non-corrinoid cobalt enzymes that catalyse the hydration of diverse nitriles to their corresponding amides

PEGylation Chemical reaction

PEGylation is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated.

Genetically modified bacteria

Genetically modified bacteria were the first organisms to be modified in the laboratory, due to their simple genetics. These organisms are now used for several purposes, and are particularly important in producing large amounts of pure human proteins for use in medicine.

Golden LEAF Biomanufacturing Training and Education Center

The Golden LEAF Biomanufacturing Training and Education Center (BTEC) is a multidisciplinary instructional center at North Carolina State University that provides education and training to develop skilled professionals for the biomanufacturing industry. Biomanufacturing refers to the use of living organisms or other biological material to produce commercially viable products. Examples include therapeutic proteins, monoclonal antibodies, and vaccines for medical use; amino acids and enzymes for food manufacturing; and biofuels and biochemicals for industrial applications. BTEC provides hands-on education and training in bioprocessing concepts and biomanufacturing methods that comply with cGMP, a set regulations published by the United States Food and Drug Administration (FDA).

Industrial enzymes are enzymes that are commercially used in a variety of industries such as pharmaceuticals, chemical production, biofuels, food & beverage, and consumer products. Due to advancements in recent years, biocatalysis through isolated enzymes is considered more economical than use of whole cells. Enzymes may be used as a unit operation within a process to generate a desired product, or may be the product of interest. Industrial biological catalysis through enzymes has experienced rapid growth in recent years due to their ability to operate at mild conditions, and exceptional chiral and positional specificity, things that traditional chemical processes lack. Isolated enzymes are typically used in hydrolytic and isomerization reactions. Whole cells are typically used when a reaction requires a co-factor. Although co-factors may be generated in vitro, it is typically more cost-effective to use metabolically active cells.

The National Prize for Applied and Technological Sciences was created in 1992 as one of the replacements for the National Prize for Sciences under Law 19169. The other two prizes in this same area are for Exact Sciences and Natural Sciences.

References

  1. "Juan Asenjo CV" (PDF). Centre for Biochemical Engineering and Biotechnology. 2011. Retrieved 2014-02-08.
  2. 1 2 "Juan Asenjo". Interamerican Network of Academies of Sciences. Retrieved 2014-02-08.
  3. 1 2 "Juan A. Asenjo, Ph.D." Centre for Biochemical Engineering and Biotechnology. Retrieved 2014-02-08.
  4. Hunter, J. B.; Asenjo, J. A. (1988). "A structured mechanistic model of the kinetics of enzymatic lysis and disruption of yeast cells". Biotechnology and Bioengineering. 31 (9): 929–43. doi:10.1002/bit.260310906. PMID   18584701.
  5. Merchuk, J. C.; Andrews, B. A.; Asenjo, J. A. (1998). "Aqueous two-phase systems for protein separation". Journal of Chromatography B. 711: 285. doi:10.1016/S0378-4347(97)00594-X.
  6. Schmidt, A. S.; Ventom, A. M.; Asenjo, J. A. (1994). "Partitioning and purification of α-amylase in aqueous two-phase systems". Enzyme and Microbial Technology. 16 (2): 131. doi:10.1016/0141-0229(94)90076-0.
  7. Andrews, B. A.; Nielsen, S; Asenjo, J. A. (1996). "Partitioning and purification of monoclonal antibodies in aqueous two-phase systems". Bioseparation. 6 (5): 303–13. PMID   9210350.
  8. Asenjo, J. A.; Ventom, A. M.; Huang, R. -B.; Andrews, B. A. (1993). "Selective Release of Recombinant Protein Particles (VLPs) from Yeast Using a Pure Lytic Glucanase Enzyme". Bio/Technology. 11 (2): 214. doi:10.1038/nbt0293-214.
  9. 1 2 "Juan Asenjo se llevó el Premio Nacional de Ciencias Aplicadas 2004". Cooperativa.cl. 2004-09-02. Retrieved 2014-02-08.
  10. "Cryophilic proteases: wash better and whiter". Centre for Biochemical Engineering and Biotechnology. Retrieved 2014-02-08.
  11. "World's first alcoholism vaccine to run preclinical trial in Chile". Santiago Times. 2013-01-22. Archived from the original on 2014-02-22. Retrieved 2014-02-08.
  12. John Lavitt (2013-11-04). "Alcohol Vaccine: A True Advance in the Treatment of Alcoholism?". Recovery View. Retrieved 2014-02-08.
  13. "Chilean senator calls for prudence in lithium development". Santiago Times. 2012-09-26. Archived from the original on 2014-02-22. Retrieved 2014-02-08.
  14. "Congreso del Futuro llamará a invertir en investigación científica". Cooperativa.cl. Retrieved 2014-02-08.